Link between liver fibrosis in MASLD, ASCVD varies by glycemic status

MedicalXpress | juil. 31, 2026

For patients with metabolic dysfunction-associated steatotic liver disease (MASLD), the association between liver fibrosis and atherosclerotic cardiovascular disease (ASCVD) varies with glycemic status, according to a study published in Hepatology Communications.